Return to Medscape coverage of: American Heart Association Scientific Sessions 2003

Print this Activity for Offline ReferenceInstructions on Taking Medscape CME
American Heart Association Scientific Sessions 2003
Advances in Cardiovascular Disease Treatment CME
November 9 - 12, 2003, Orlando, Florida

This activity is not sanctioned by, nor a part of, the American Heart Association.

Release Date: December 30, 2003; Valid for credit through December 30, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


Contents of This CME Activity
  1. New Findings in Treatments for Post-MI, Atrial Fibrillation, and Heart Failure Patients
    Ileana L. Piña, MD
    A review of the most widely discussed and debated highlights from the 2003 AHA meeting, including the VALIANT, SPORTIF V, and DEFINITE trials.

  2. From Myocardial Infarction to Heart Failure -- Highlights From the 2003 AHA
    Jonathan Howlett, MD, FRCPC
    The themes with the greatest implications for cardiovascular care at AHA 2003, including reviews of the results of the most important late-breaking clinical trials as well as risk stratification.


 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the American Heart Association. These materials and the related activity are not sanctioned by the American Heart Association or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2003 Medscape.

 
Novartis
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.